This is a big step toward modernizing drug safety oversight by the FDA. Starting August 22, 2025, the agency will publish daily updates from the FDA Adverse Event Reporting System (FAERS), instead of quarterly releases.
It makes a difference for it leads to:
1. Faster detection of safety signals – Real-time access means emerging risks can be spotted sooner, potentially leading to quicker interventions.
2. Greater transparency – Patients, providers, researchers, and industry stakeholders will no longer wait months to access critical safety data.
3. Modern infrastructure – This change builds on the FDA’s broader push for data modernization and digital transformation.
Of course, do remember that FAERS data doesn’t prove causation—reports may be incomplete or duplicated. Still one has to agree that, daily reporting is a milestone in making safety monitoring faster, more open, and more responsive.
